Position: Home>About Us>Management Team

Management Team

  Genor has build a highly experienced and fully integrated management team, each member with more than 15~20 years of industry experience, and coming from major biopharmaceutical companies of the US and China. Their expertise covers each key steps of mAb drug research and development.

Zhou, Joe, Ph. D. ‐ CEO

Dr. Zhou, Xinhua (Joe) is the CEO of Genor Biopharma Co. Ltd. He has been selected as a national expert of the TOP 1000 TALENTS program in China since 2010. Dr. Zhou also is a visiting professor teaching Master's Degree Program in International Pharmaceutical Engineering Management (IPEM) at Peking University, China. He is an invited vice-chair of Biopharmaceuticals Committee under China Pharmaceuticals Society, the Founder and first Chair of China Protein Drug Quality Alliance (CPDQA), the Chair of Biological Drug Product and Process Committee of China ISPE, and the Chair of Amgen Aluminums Association (AAA) in China. Previously, Dr. Zhou was Scientific Director at Amgen. He has over 20-years experience of process development, multiple project management capacity in cGMP and non-GMP reproducible purification/production of protein/antibody therapeutics from FIH to CPD with depth knowledge of CHO clone selection, cell culture optimization, viral clearance, real time analytical assays, formulation and product specification for drug substances and drug products.

Kan, Steve, Ph.D ‐ CMC

Steve Kan is the Chief TechnologyOfficer and Head of Quality of Genor Biopharm Co. Ltd. He has 25 years ofUS/Canada experience and 4 years of China biotech experience. Beforereturning to China in 2013, Dr. Kan worked at several American pharmaceuticaland biotechnology companies including Monsanto, Pfizer Global Biologics,Allergan, and Ionis Pharmaceuticals, specializing in latestage development ofbiopharmaceuticals.  He participated in and led the quality establishmentof more than 10 drug development projects, and is highly experienced withproject CMC management, GMP quality system, product characterization andstructural elucidation, analytical method development, qualification and ICHvalidation, as well as regulatory filings and quality standard of clinical supplies.



Chen, Robert - Vice President

Mr. Robert Chen is Vice President and Head of BD & Strategy at Genor Biopharma Co. Ltd. He has more than 15 years of industrial experience in biopharmaceutical industry in China, incl more than ten years of business development experience and two years in biopharmaceutical venture capital arena.

Li, Jason - Vice President

Jason Li is Vice President of Downstream Process and Technology Transfer of Genor Biopharma. He has over 15 years of experience in Biotechnology Industry, including over 12 years of Development and manufacturing of biopharmaceuticals in U.S., such as Global Process Engineering in Amgen and Process Development in Invitrogen.

Qi Zhang - Medical Director

Qi Zhang, Medical director of MedicalDepartment, 12 years of clinical practice experience in hospital and 8 years ofmedical affairs experience in Biopharmaceutical industry. Worked atpharmaceutical companies including Genzyme, Sanofi, Cp Guojian, Green Valley,specializing in the premarketing & marketing medical affairs in oncology& transplantation. Highly experienced with R&D strategy, design,development and management of clinical trial, as well as regulatory IND, NDA,BLA filings.

Cheng, Fiona - Senior Director

Fiona (Huiyang) Cheng is Senior Director of Pre-clinical, Clinical & Registration of Genor Biopharma. She has more than 15 years of broad technical and managerial experience in the pharmaceutical business, with a thorough knowledge of GMP/GLP regulations from FDA, EMEA, MHRA, TGA, WHO as well as ICH requirements of cGMP.            


Xu Shuiqing - Director

Shuiqing Xu is Director of Upstream Process Development in Genor Biopharma. He has more than 15 years of biopharmaceutical industrial experience focusing on process development and manufacturing. As major technical personnel, he took part in the development of new recombinant adenovirus and monoclonal antibody drugs which have been launched in the market. He has also established technology platform of large scale mammalian cell culture in Genor Biopharma.

Duan Qingtang - Executive Deputy General Manager

Duan Qingtang is Executive Deputy General Manager of YuxiGenor. He is responsible for the operation and management of monoclonal antibody industrialization base of Genor BioPharma Co.,Ltd. Owns 13 years of experience on biomedical industry construction, production and operation management, and has presided over a number of large-scale biopharmaceutical industry construction projects.